Evaluation of a Treatment Manual for Risperidone Long-Acting Injectable

By Docherty John   Jones Robert   Turkoz Ibrahim   Lasser Robert   Kujawa Mary  

Community Mental Health Journal, Vol. 43, Iss. 3, 2007-06 ,pp. : 267-280

Springer Publishing Company

Access to resources Recommend Favorite

What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?

By Samalin Ludovic   Nourry Aurore   Charpeaud Thomas   Llorca Pierre-Michel  

Nordic Journal of Psychiatry, Vol. 68, Iss. 4, 2014-05 ,pp. : 227-235

Informa Healthcare

Access to resources Recommend Favorite

Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

By Mohamed Somaia   Rosenheck Robert   Harpaz-Rotem Ilan   Leslie Douglas   Sernyak Michael  

Psychiatric Quarterly, Vol. 80, Iss. 4, 2009-12 ,pp. : 241-249

Springer Publishing Company

Access to resources Recommend Favorite

Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study

By Braunig Peter   Sacchetti Emilio   Medori Rossella  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 1, 2008-01 ,pp. : 74-77

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg

By Mauri Massimo Carlo   Turner Martin   Volonteri Lucia   Medori Rossella   Maier Wolfgang  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 1, 2009-03 ,pp. : 36-47

Ashgate Publishing Ltd

Access to resources Recommend Favorite